Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
Saudi Arabia Cancer Biopsy Market By Product (Instruments, Kits & Consumables, Services), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Others), By Region and Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Cancer Biopsy Market was valued at USD 148.26 Million in 2024 and is expected to reach USD 192.64 Million by 2030 with a CAGR of 4.66% during the forecast period. Cancer is one of the lea...
January 2025
85 pages
UAE Breast Cancer Drugs Market By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy), By Cancer Type (Hormone Receptor, HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others Distribution Channel), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
UAE Breast Cancer Drugs Market was valued at USD 11.56 Billion in 2024 and is expected to reach USD 18.97 Billion with a CAGR of 8.56% through 2030. The UAE Breast Cancer Drugs Market is experiencing...
January 2025
82 pages
Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Precision Oncology Market Growth & Trends The global precision oncology market size is expected t%li%reach USD 201.96 billion by 20...
January 2025
180 pages
Global Metastatic Bone Disease Market Size Study, By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), By Origin of Metastasis (Breast, Lung, Thyroid, Kidney, Prostate, Others), By Treatment (Medication, Radiation Therapy, Surgical Intervention, Tumor Ablation Therapy), and Regional Forecasts 2022-2032
US$ 3,750.00
This substantial growth is attributed to the rising global incidence of cancer and advancements in therapeutic approaches that include radiopharmaceuticals, bisphosphonates, and other bone-targeting a...
January 2025
285 pages
Global Neuroendocrine Tumor Treatment Market Size Study, By Type (Meningiomas, Adrenal Cancer, Carcinoid Tumors, Paraganglioma), By Product (Somatostatin Analogs, Targeted Therapy, Others), By Site (Lung, Pancreas, Small Intestine, Stomach, Others), By End Use (Hospitals, Clinics, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The global neuroendocrine tumor treatment market was valued at USD 2.51 billion in 2023 and is projected to grow at a CAGR of 6.0% during the forecast period 2024-2032, reaching a market size of USD 4...
January 2025
285 pages
Global Kidney Cancer Drugs Market Size Study, by Type (Renal Cell Carcinoma (RCC), Transitional Cell Cancer, Wilms Tumor, Renal Sarcoma), by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), by Drug Class (Angiogenesis Inhibitors, Monoclonal Antibodies, mTOR Inhibitors, Cytokine Immunotherapy), by Route of Administration (Oral, Intravenous, Subcutaneous), by End Use (Hospital Pharmacies, Retail Pharmacies, Others), and Regional Forecasts 2022–2032
US$ 3,750.00
The global kidney cancer drugs market was valued at USD 6.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.9% over the forecast period from 2024 to 2032. This g...
January 2025
285 pages
Tumor Ablation Market By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Ablation Technologies), By Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Bone Cancer, Other): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
The tumor ablation market was valued at $1.6 billion in 2023, and is estimated to reach $7.5 billion by 2035, growing at a CAGR of 13.6% from 2024 to 2035.Tumor ablation is a medical procedure used to...
January 2025
372 pages
Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Pancreatic Cancer Treatment Market Growth & Trends The global pancreatic cancer treatment market size is anticipated treach USD 5.8...
December 2024
153 pages
Artificial Intelligence (AI) in Cancer
US$ 4,650.00
Report : The report highlights AI technology's current and future market potential for cancer applications. It provides a detailed analysis of the market drivers, restraints and opportunities. The rep...
November 2024
111 pages
Lung Cancer Therapeutics – A Global Market Overview
US$ 4,500.00
Lung Cancer Therapeutics Market Trends and Outlook Lung cancer, also known as lung carcinoma, is a malignant tumor that begins in the lungs and is caused by genetic damage to airway cells from smoking...
November 2024
254 pages
Breast Cancer Therapeutics – A Global Market Overview
US$ 4,500.00
Breast Cancer Therapeutics Market Trends and Outlook Breast cancer occurs when uncontrolled growth of cells in the breast leads to the formation of a tumor that can invade nearby tissues or spread to...
November 2024
257 pages
Cervical Cancer Treatment – A Global Market Overview
US$ 4,500.00
Cervical Cancer Treatment Market Trends and Outlook Cervical cancer develops in the cervix and is often associated with Human Papillomavirus (HPV) infections, progressing slowly and beginning with dys...
November 2024
250 pages
Global Oncology Pharmaceuticals Market
US$ 4,650.00
Report This report seeks to deliver an in-depth analysis of the worldwide oncology pharmaceuticals (cancer medications) market. It includes a thorough overview of various types of oncology drugs, such...
October 2024
181 pages
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,450.00
The global lung cancer therapy market was valued at US$32.50 billion in 2023. The market value is expected to reach US$70.39 billion by 2029. Lung cancer therapy is a critical area of oncology, focusi...
September 2024
184 pages
Asia Pacific Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
US$ 3,550.00
The Asia Pacific breast cancer therapeutics market was valued at US$ 6,986.37 million in 2022 and is expected to reach US$ 15,819.83 million by 2030; it is estimated to grow at a CAGR of 10.8% from 20...
March 2024
106 pages
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
US$ 4,175.00
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospita...
February 2024
209 pages
Multi-Cancer Diagnostic Tests: Global Market Outlook
US$ 2,950.00
Report : The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and chal...
February 2024
50 pages
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
US$ 4,650.00
The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in ... should reach $27.4 billion in 2021, with a CAGR of 7.2 %. Surgical and radiation therapy as a segment reached nearly $14.4 billion in 2016 and should reach $20.8 billion ...
January 2024
157 pages
Global Gastric Cancer Diagnostic Market: Analysis By Product Type (Reagents and Consumables and Instruments), By Disease Type (Adenocarcinoma, Gastric Lymphoma and Others), By End User (Hospitals, Oncology Specialty Clinics, Diagnostic Labs, Cancer Research Institutes And Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
US$ 2,250.00
Gastric cancer diagnostic involves a comprehensive process of identifying stomach cancer through clinical evaluation, imaging studies like endoscopy and CT scans, biopsy for tissue examination, and bl...
January 2024
143 pages
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
300 pages
Cancer Diagnostic Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
450 pages
Oncology Collaboration and Licensing Deals 2019-2023
US$ 3,995.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
October 2023
1600 pages
Global Cervical Cancer Therapeutics Market 2023
US$ 3,350.00
The global cervical cancer therapeutics market was valued at USD 5.66 billion in 2022 and is projected to reach USD 7.14 billion by 2029, exhibiting a compound annual growth rate of 3.3% between 2023...
September 2023
94 pages
Oncology Biomarkers: Global Markets
US$ 4,650.00
Report : This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall in...
June 2023
186 pages
Colorectal Cancer Screening Market: By End user (Hospitals, Diagnostic laboratories and Others); By Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
US$ 4,950.00
Colorectal Cancer Screening Market: By End user (Hospitals, Diagnostic laboratories and Others); By Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy), And Reg...
June 2023
251 pages
Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application, End User, and Region Analysis - Analysis and Forecast, 2023-2032
US$ 2,750.00
Global Multicancer Screening Market Industry Overview The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during...
April 2023
228 pages
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
US$ 4,950.00
... various cancer/tumor profiling technologies and their adoption pattern. It aims at estimating the market size and future growth potential of cancer/tumor profiling market and the different segments such as by technology, cancer ...
November 2022
295 pages
Interventional Oncology Global Market - Forecast To 2029
US$ 4,950.00
Interventional Oncology (IO) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, B...
September 2022
378 pages
Head and Neck Cancer Therapeutics: Global Markets
US$ 5,500.00
Report : This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of quantitative and qualitative data, to help businesses develop gr...
August 2022
148 pages
RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), End User (Pharma, Payer) - Global Forecast to 2029
US$ 4,175.00
RWE Oncology Solutions Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillanc...
July 2022
200 pages
Cancer Supportive Care Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (G-CSFs, ESAs, Opioids), By Region (APAC, North America, Europe, MEA), And Segment Forecasts, 2022 - 2030
US$ 5,950.00
... to drive growth of the global cancer supportive care drugs market. High efficiency of these drugs in controlling the adverse effects of cancer and its treatment is projected ... major brands such as Epogen North America led the cancer supportive care drugs market in 2018 and is expected to maintain its position ...
May 2022
89 pages
Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods {Biopsy, Imaging, Endoscopy, Others} v/s Treatment Type {Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy}), By Treatment Type (By Disease Indication {Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer}, By Route of Administration {Injectable, Oral}, By Therapeutic Class {PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors}), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Company, Opportunities and Forecast, 2027
US$ 4,500.00
Global head and neck cancer therapeutics market value in 2021 was USD2024.33 million, which is expected to grow further with a CAGR of 7.22% during the forecast period, 2023-2027, to achieve the marke...
April 2022
358 pages
Artificial Intelligence in the Cancer Market
US$ 4,950.00
Product Overview For years, artificial intelligence (AI) has caught society's interest and generated excitement about its potential tenhance our lives. AI is already a part of our everyday lives, as w...
April 2022
334 pages
Cancer Stem Cells: Technologies and Global Markets
US$ 5,500.00
The global market for cancer stem cells will grow from ... million by 2022 with a CAGR of 20.4%. Breast cancer stem cell market will grow from $171 million in 2017 to $ ... million by 2022 with a CAGR of 21.3%. The reverse transcriptase inhibitors market is expected to grow from $16.9 billion in 2017 to $20.7 billion ...
December 2021
206 pages
India Oncology NGS Market Size, Share & Trends Analysis Report By End-use (Clinical Research, Hospitals & Clinics), By Technology, By Application, By Product & Service, By Workflow, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours India Oncology NGS Market Growth & Trends The India oncology NGS market is expected to reach USD 70.60 million by 2028, registeri...
December 2021
158 pages
Global Interventional Oncology Market
US$ 5,500.00
Report : The current report highlights the current and future market potential of IO along with a detailed analysis of the competitive environment, regulatory scenario, technology, and the drivers, re...
December 2021
108 pages
